CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-12-14 | Berg Jeffrey Alan Interim CEO | Gift | −100,000 | 17,117,258 | ||
| 2012-09-19 | Berg Jeffrey Alan INTERIM CEO | Purchase | +10,000 | $0.19 | $2K | 17,217,258 |
| 2012-09-13 | Berg Jeffrey Alan INTERIM CEO | Purchase | +1,500 | $0.20 | $305 | 17,207,258 |
| 2012-09-11 | Berg Jeffrey Alan INTERIM CEO | Purchase | +7,000 | $0.19 | $1K | 17,160,758 |
| 2012-09-11 | Berg Jeffrey Alan INTERIM CEO | Purchase | +40,000 | $0.19 | $8K | 17,200,758 |
| 2012-09-11 | Berg Jeffrey Alan INTERIM CEO | Purchase | +5,000 | $0.19 | $950 | 17,205,758 |
| 2012-09-10 | Berg Jeffrey Alan INTERIM CEO | Purchase | +1,110,684 | $0.17 | $189K | 17,153,758 |
| 2012-09-07 | Berg Jeffrey Alan INTERIM CEO | Purchase | +1,000 | $0.18 | $179 | 16,043,074 |
| 2012-09-06 | Berg Jeffrey Alan INTERIM CEO | Purchase | +5,000 | $0.17 | $849 | 16,034,074 |
| 2012-09-06 | Berg Jeffrey Alan INTERIM CEO | Purchase | +4,000 | $0.17 | $680 | 16,038,074 |
| 2012-09-06 | Berg Jeffrey Alan INTERIM CEO | Purchase | +4,000 | $0.16 | $640 | 16,042,074 |
| 2012-09-05 | Berg Jeffrey Alan INTERIM CEO | Purchase | +1,431 | $0.16 | $222 | 16,026,074 |
| 2012-09-05 | Berg Jeffrey Alan INTERIM CEO | Purchase | +2,800 | $0.16 | $447 | 16,028,874 |
| 2012-09-05 | Berg Jeffrey Alan INTERIM CEO | Purchase | +200 | $0.16 | $32 | 16,029,074 |
| 2012-08-16 | Khuchua Vladimir EVP and Chief Product Officer | Purchase | +4,200 | $0.22 | $924 | 272,700 |
| 2012-08-06 | Khuchua Vladimir EVP/Chief Product Officer | Grant or award | +250,000 | 268,500 | ||
| 2012-08-06 | George Christopher Allen Chief Information Officer | Grant or award | +60,000 | 60,600 | ||
| 2012-08-06 | Berger Kendra Chief Financial Officer | Grant or award | +150,000 | 188,750 | ||
| 2012-07-02 | Yanover Paul Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 30,000 | ||
| 2012-06-08 | Mitgang Steve Director | Grant or award · Stock Options (Right to Buy) | +20,000 | 70,000 |
Page 24 of 33 · 657 trades